These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 25188871)
21. Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor. Abdul-Ridha A; Lane JR; Mistry SN; López L; Sexton PM; Scammells PJ; Christopoulos A; Canals M J Biol Chem; 2014 Nov; 289(48):33701-11. PubMed ID: 25326383 [TBL] [Abstract][Full Text] [Related]
22. Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold. Kuduk SD; Chang RK; Di Marco CN; Pitts DR; Greshock TJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Ray WJ J Med Chem; 2011 Jul; 54(13):4773-80. PubMed ID: 21682298 [TBL] [Abstract][Full Text] [Related]
23. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry. Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772 [TBL] [Abstract][Full Text] [Related]
24. Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor. Huynh T; Valant C; Crosby IT; Sexton PM; Christopoulos A; Capuano B J Med Chem; 2013 Oct; 56(20):8196-200. PubMed ID: 24074052 [TBL] [Abstract][Full Text] [Related]
25. Role for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice. Gould RW; Dencker D; Grannan M; Bubser M; Zhan X; Wess J; Xiang Z; Locuson C; Lindsley CW; Conn PJ; Jones CK ACS Chem Neurosci; 2015 Oct; 6(10):1683-95. PubMed ID: 26176846 [TBL] [Abstract][Full Text] [Related]
26. Utility of an "Allosteric Site-Impaired" M Moo EV; Sexton PM; Christopoulos A; Valant C Mol Pharmacol; 2018 Nov; 94(5):1298-1309. PubMed ID: 30213802 [TBL] [Abstract][Full Text] [Related]
27. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors. Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965 [TBL] [Abstract][Full Text] [Related]
28. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site. Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086 [TBL] [Abstract][Full Text] [Related]
29. Design of benzophenone-containing photoactivatable linear vasopressin antagonists: pharmacological and photoreactive properties. Ponthieux S; Cabot J; Mouillac B; Seyer R; Barberis C; Carnazzi E J Med Chem; 2005 May; 48(9):3379-88. PubMed ID: 15857144 [TBL] [Abstract][Full Text] [Related]
30. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites. Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966 [TBL] [Abstract][Full Text] [Related]
32. T-495, a novel low cooperative M Mandai T; Sako Y; Kurimoto E; Shimizu Y; Nakamura M; Fushimi M; Maeda R; Miyamoto M; Kimura H Pharmacol Res Perspect; 2020 Feb; 8(1):e00560. PubMed ID: 31990455 [TBL] [Abstract][Full Text] [Related]
33. Hybrid ortho/allosteric ligands for the adenosine A(1) receptor. Narlawar R; Lane JR; Doddareddy M; Lin J; Brussee J; Ijzerman AP J Med Chem; 2010 Apr; 53(8):3028-37. PubMed ID: 20345101 [TBL] [Abstract][Full Text] [Related]
34. Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor. Mistry SN; Lim H; Jörg M; Capuano B; Christopoulos A; Lane JR; Scammells PJ ACS Chem Neurosci; 2016 May; 7(5):647-61. PubMed ID: 26891194 [TBL] [Abstract][Full Text] [Related]
36. Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor. Espinoza-Fonseca LM; Trujillo-Ferrara JG FEBS Lett; 2005 Dec; 579(30):6726-32. PubMed ID: 16310776 [TBL] [Abstract][Full Text] [Related]
37. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site. Ploug M Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416 [TBL] [Abstract][Full Text] [Related]
38. Benzophenone-type photoactivatable derivatives of alpha-neurotoxins and alpha-conotoxins in studies on Torpedo nicotinic acetylcholine receptor. Kasheverov I; Zhmak M; Chivilyov E; Saez-Brionez P; Utkin Yu; Hucho F; Tsetlin V J Recept Signal Transduct Res; 1999; 19(1-4):559-71. PubMed ID: 10071785 [TBL] [Abstract][Full Text] [Related]
39. Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line. Chen AN; Malone DT; Pabreja K; Sexton PM; Christopoulos A; Canals M J Biomol Screen; 2015 Jun; 20(5):646-54. PubMed ID: 25534830 [TBL] [Abstract][Full Text] [Related]